Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives

Christopher T. Minson, John R. Halliwill, Tamica M. Young, Michael Joseph Joyner

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Background - We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or 'low-hormone' phase (LH) and 2 to 3 weeks later during the 'high-hormone' phase (HH) of oral contraceptive (OC) use in 9 women. Methods and Results - Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. Conclusions - Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.

Original languageEnglish (US)
Pages (from-to)1473-1476
Number of pages4
JournalCirculation
Volume102
Issue number13
StatePublished - Sep 26 2000

Fingerprint

Baroreflex
Oral Contraceptives
Hormones
Blood Pressure
Muscles
Nitroprusside
Phenylephrine
Menstrual Cycle
Norepinephrine
Arterial Pressure
Placebos

Keywords

  • Blood pressure
  • Estrogens
  • Nervous system, autonomic
  • Progesterone

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Minson, C. T., Halliwill, J. R., Young, T. M., & Joyner, M. J. (2000). Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation, 102(13), 1473-1476.

Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. / Minson, Christopher T.; Halliwill, John R.; Young, Tamica M.; Joyner, Michael Joseph.

In: Circulation, Vol. 102, No. 13, 26.09.2000, p. 1473-1476.

Research output: Contribution to journalArticle

Minson, CT, Halliwill, JR, Young, TM & Joyner, MJ 2000, 'Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives', Circulation, vol. 102, no. 13, pp. 1473-1476.
Minson, Christopher T. ; Halliwill, John R. ; Young, Tamica M. ; Joyner, Michael Joseph. / Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. In: Circulation. 2000 ; Vol. 102, No. 13. pp. 1473-1476.
@article{b8016974758f4557bbf1f00439c0c2e4,
title = "Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives",
abstract = "Background - We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or 'low-hormone' phase (LH) and 2 to 3 weeks later during the 'high-hormone' phase (HH) of oral contraceptive (OC) use in 9 women. Methods and Results - Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. Conclusions - Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.",
keywords = "Blood pressure, Estrogens, Nervous system, autonomic, Progesterone",
author = "Minson, {Christopher T.} and Halliwill, {John R.} and Young, {Tamica M.} and Joyner, {Michael Joseph}",
year = "2000",
month = "9",
day = "26",
language = "English (US)",
volume = "102",
pages = "1473--1476",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "13",

}

TY - JOUR

T1 - Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives

AU - Minson, Christopher T.

AU - Halliwill, John R.

AU - Young, Tamica M.

AU - Joyner, Michael Joseph

PY - 2000/9/26

Y1 - 2000/9/26

N2 - Background - We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or 'low-hormone' phase (LH) and 2 to 3 weeks later during the 'high-hormone' phase (HH) of oral contraceptive (OC) use in 9 women. Methods and Results - Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. Conclusions - Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.

AB - Background - We tested sympathetic and cardiovagal baroreflex sensitivity during the placebo or 'low-hormone' phase (LH) and 2 to 3 weeks later during the 'high-hormone' phase (HH) of oral contraceptive (OC) use in 9 women. Methods and Results - Sympathetic baroreflex sensitivity was assessed by intravenous doses of sodium nitroprusside and phenylephrine and defined as the slope relating muscle sympathetic nerve activity (by microneurography) and diastolic blood pressure. Cardiovagal baroreflex sensitivity was defined as the slope relating R-R interval and systolic blood pressure. No difference was observed for resting muscle sympathetic nerve activity or plasma norepinephrine levels. However, sympathetic baroreflex sensitivity was greater and mean arterial pressure was higher during the LH than in the HH phase. Similarly, cardiovagal baroreflex sensitivity was greater in the LH than in the HH phase. Conclusions - Sympathetic and cardiovagal baroreflex sensitivities change during the 28-day course of OC use. Furthermore, changes in baroreflex sensitivity with OC differ from changes in baroreflex sensitivity during the normal menstrual cycle.

KW - Blood pressure

KW - Estrogens

KW - Nervous system, autonomic

KW - Progesterone

UR - http://www.scopus.com/inward/record.url?scp=0034718438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034718438&partnerID=8YFLogxK

M3 - Article

C2 - 11004135

AN - SCOPUS:0034718438

VL - 102

SP - 1473

EP - 1476

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 13

ER -